DURECT CORP Intellectual Property Contracts & Agreements

25 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Amendment No. 2 to Exclusive License Agreement between the Company and Virginia Commonwealth University Intellectual Property Foundation dated March 6, 2018
License Agreements
DURECT CORP
Pharmaceuticals
2024
Amendment No. 1 to Exclusive License Agreement between the Company and Virginia Commonwealth University Intellectual Property Foundation dated July 2, 2015
License Agreements
DURECT CORP
Pharmaceuticals
2024
First Amendment to License Agreement by and between the Company and Innocoll Pharmaceuticals Limited dated September 19, 2022
License Agreements
DURECT CORP
Pharmaceuticals
2022
License agreement by and between the Company and Innocoll Pharmaceuticals Limited dated December 21, 2021
License Agreements
DURECT CORP
Pharmaceuticals
CA
2022
Amendment No. 2 to Exclusive License Agreement between the Company and Virginia Commonwealth University Intellectual Property Foundation dated March 6, 2018
License Agreements
DURECT CORP
Pharmaceuticals
2021
Amendment No. 1 to Exclusive License Agreement between the Company and Virginia Commonwealth University Intellectual Property Foundation dated July 2, 2015
License Agreements
DURECT CORP
Pharmaceuticals
2021
License Agreement between the Company and Gilead Sciences, Inc. dated July 19, 2019
License Agreements
DURECT CORP
Pharmaceuticals
DE
2019
Amendment No. 2 to Exclusive License Agreement between the Company and Virginia Commonwealth University Intellectual Property Foundation dated March 6, 2018
License Agreements
DURECT CORP
Pharmaceuticals
2018
Amendment No. 1 to Exclusive License Agreement between the Company and Virginia Commonwealth University Intellectual Property Foundation dated July 2, 2015
License Agreements
DURECT CORP
Pharmaceuticals
2018
Exclusive License Agreement between the Company and Virginia Commonwealth University Intellectual Property Foundation dated December 5, 2012
License Agreements
DURECT CORP
Pharmaceuticals
2018
ASSETTRANSFER AND LICENSE AGREEMENT
License Agreements
DURECT CORP
Pharmaceuticals
NY
2014
AMENDMENT NO. 1 TO DEVELOPMENT AND LICENSE AGREEMENT
License Agreements
DURECT CORP
Pharmaceuticals
2013
DEVELOPMENT AND LICENSE AGREEMENT
License Agreements
DURECT CORP
Pharmaceuticals
CA
2013
DEVELOPMENT AND LICENSE AGREEMENT BETWEEN DURECT CORPORATION AND ZOGENIX, INC. DATED AS OF JULY 11, 2011
License Agreements
DURECT CORP
Pharmaceuticals
CA
2011
AMENDMENT NO. 2 TODEVELOPMENT AND LICENSE AGREEMENT
License Agreements
DURECT CORP
Pharmaceuticals
2011
DEVELOPMENT AND LICENSE AGREEMENT
License Agreements
DURECT CORP
Pharmaceuticals
NY
2008
AMENDMENT NO. 1 TO LICENSE AGREEMENT
License Agreements
DURECT CORP
Pharmaceuticals
2008
DEVELOPMENT AND LICENSE AGREEMENT
License Agreements
DURECT CORP
Pharmaceuticals
2007
DEVELOPMENT AND LICENSE AGREEMENT
License Agreements
DURECT CORP
Pharmaceuticals
CA
2006
LICENSE AGREEMENT
License Agreements
DURECT CORP
Pharmaceuticals
NY
2005
LICENSE AND COMMERCIALIZATION AGREEMENT
License Agreements
DURECT CORP
Pharmaceuticals
CA
2004
Re: Amendment to Development, Commercialization and Supply License Agreement
License Agreements
DURECT CORP
Pharmaceuticals
2004
DEVELOPMENT AND LICENSE AGREEMENT
License Agreements
DURECT CORP
Pharmaceuticals
CA
2003
DEVELOPMENT, COMMERCIALIZATION AND SUPPLY LICENSE AGREEMENT BETWEEN DURECTCORPORATION AND
License Agreements
DURECT CORP
Pharmaceuticals
DE
2003
DEVELOPMENT AND LICENSE AGREEMENT
License Agreements
DURECT CORP
Pharmaceuticals
NY
2003